Eurofins Scientific Se EUROFINS S.../ FR0014000MR3 /
5/24/2024 6:12:04 PM | Chg. - | Volume | Bid5:40:09 PM | Ask5:40:09 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
57.40EUR | - | 2,866 Turnover: 135,104.08 |
-Bid Size: - | -Ask Size: - | 10.74 bill.EUR | 0.90% | 18.82 |
Newsfile Corp
1:00 PM
Tudor Gold Discovers a Fourth High-Grade Gold Target, Supercell-1D (SC-1D) at Treaty Creek, Golden T...
Newsfile Corp
10/3
Nanalysis Scientific Corp. to Present at the 2024 Cantech Letter Conference in Toronto, ON
GlobeNewswire
8/26
Latest Dupixent® (dupilumab) and Itepekimab Data at ERS Highlight Scientific Innovation and Leadersh...
GlobeNewswire
8/22
SciSparc: MitoCareX Appointed Professor Nir Peled, Seasoned Oncologist, to its Scientific Advisory B...
GlobeNewswire
8/22
Starton Therapeutics Strengthens Clinical Development Strategy Following Successful Scientific Advis...
GlobeNewswire
8/19
SILK Alert: Monsey Firm of Wohl & Fruchter Renews Investigation of the Proposed Sale of Silk Road Me...
GlobeNewswire
8/19
Calibre Scientific Acquires Industrial Glassware, a U.S. Manufacturer and Provider of Laboratory Sup...
GlobeNewswire
8/16
Liquidia Announces Poster Presentations at the PHA 2024 International PH Conference and Scientific S...
GlobeNewswire
8/15
Milestone Scientific Provides Business Update and Reports Financial Results for the Second Quarter o...
GlobeNewswire
8/14
Syntec Optics Holdings, Inc. (Nasdaq: OPTX) Reports Second Quarter 2024 Financial Results
GlobeNewswire
8/14
Calibre Scientific Acquires Greyhound Chromatography, a UK Provider of Analytical Standards and Chro...
GlobeNewswire
8/13
Syntec Optics (Nasdaq: OPTX) to Host Conference Call to Discuss Financial Results and Business Updat...
GlobeNewswire
8/12
Milestone Scientific Schedules Second Quarter 2024 Financial Results and Business Update Conference ...
GlobeNewswire
8/7
Calibre Scientific Acquires Acefesa, a Provider of Laboratory Consumables and Equipment in Spain
GlobeNewswire
8/6
Clearmind Medicine: New Scientific Publication Shows MEAI's Potential as a Novel Weight Loss Drug
GlobeNewswire
8/1
Myriad Genetics Advances International Reorganization and Completes Sale of EndoPredict Business to ...